The effect of IL17 and IL23 inhibitors on hematological parameters and C-reactive protein in psoriasis patients

CONCLUSION: Our study supports the view that MPV and CRP can be used in patients with psoriasis using IL17 and IL23 inhibitors, while NLR and PLR parameters derived from blood count may not be used to evaluate treatment response, contrary to other studies.PMID:37897439 | DOI:10.1080/15569527.2023.2275020

Source: Cutaneous and Ocular Toxicology - October 28, 2023 Category: Toxicology Authors: Mustafa Esen Source Type: research